| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Wintermute Biomedical is an antimicrobials-focused pharmaceutical company located in Melbourne, Australia and Missoula, Montana. We have developed a novel platform for harnessing the antimicrobial activity of fatty acids, with a focus on developing a next-generation treatment for Shingles. Our lead product Solexan‚Ñ¢ is now in clinical trials. Our vision is to make Solexan‚Ñ¢ available for the millions of people who fall victim to Shingles each year. |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://www.wintermutebiomedical.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | Melbourne, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/wintermutebiomedical |
| Founders: | |
| Awards won: | |
